MarkAlanLevstikDO

PubMed

• Increased Risk of Severe Recurrence of Hepatitis C Virus in Liver Transplant Recipients of Donation After Cardiac Death Allografts.
  Hernandez-Alejandro, R., Croome, K.P., Quan, D., Mawardi, M., Chandok, N., Dale, C., McAlister, V., Levstik, M.A., Wall, W., Marotta, P.> ;Transplantation. 2011 Sep 27
• The hepatopulmonary syndrome.
  Ghent, C.N., Levstik, M.A., Marotta, P.J.> ;N Engl J Med. 2008 Aug 21
• Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe.
  Myers, R. P., Pomier-Layrargues, G., Kirsch, R., Pollett, A., Beaton, M., Levstik, M., Duarte-Rojo, A., Wong, D., Crotty, P., Elkashab, M.> ;J Hepatol. 2012 Mar
• The role of hepatitis B immunoglobulin in hepatitis B related liver transplantation: Canadian Transplant Centre Position Paper.
  Levstik, M., Wong, P., Greanya, E. D., Yoshida, E. M.> ;Ann Hepatol. 2011 Sep 14
• Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients.
  Myers, R. P., Pomier-Layrargues, G., Kirsch, R., Pollett, A., Duarte-Rojo, A., Wong, D., Beaton, M., Levstik, M., Crotty, P., Elkashab, M.> ;Hepatology. 2012 Jan
• Long-term outcomes of emergency liver transplantation for acute liver failure.
  Chan, G., Taqi, A., Marotta, P., Levstik, M., McAlister, V., Wall, W., Quan, D.> ;Liver Transpl. 2009 Dec 01
• Is serum hepcidin causative in hemochromatosis? Novel analysis from a liver transplant with hemochromatosis.
  Adams, P. C., McAlister, V., Chakrabarti, S., Levstik, M., Marotta, P.> ;Can J Gastroenterol. 2008 Oct 01
• The clinical consequences of utilizing donation after cardiac death liver grafts into hepatitis C recipients.
  Mawardi, M., Aba Alkhail, F., Katada, K., Levstik, M., Quan, D., Wall, W., Marotta, P., Hernandezalejandro, R.> ;Hepatol Int. 2011 Sep
• Ranking in Canadian gastroenterology residency match: what do residents and program directors want?
  Khan, K., Levstik, M.> ;Can J Gastroenterol. 2010 Jun
• Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
  Parfitt, J. R., Marotta, P., Alghamdi, M., Wall, W., Khakhar, A., Suskin, N. G., Quan, D., McAllister, V., Ghent, C., Levstik, M., McLean, C., Chakrabarti, S., Garcia,...> ;Liver Transpl. 2007 Apr
• Clinical recommendations for the use of recombinant human erythropoietin in patients with hepatitis C virus being treated with ribavirin.
  Sherman, M., Cohen, L., Cooper, M. A., Elkashab, M., Feinman, V., Fletcher, D., Girgrah, N., Heathcote, J., Levstik, M., McNaull, W. B., Wong, D., Wong, F., Yim, C.> ;Can J Gastroenterol. 2006 Jul
• The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort.
  Castellino, S., Lensing, S., Riely, C., Rai, S. N., Davila, R., Hayden, R. T., Fleckenstein, J., Levstik, M., Taylor, S., Dean, P. J., Kippenbrock, S., Pope, J., Carr,...> ;Blood. 2004 Apr 1
• Hepatitis C infection during treatment for childhood cancer: pitfalls in diagnosis and management.
  Swilley, S., Strickland, D. K., Davila, R., Levstik, M., Ribeiro, R., Hudson, M. M.> ;Med Pediatr Oncol. 2002 Jul
• Eligibility and exclusion of hemochromatosis patients as voluntary blood donors.
  Levstik, M., Adams, P. C.> ;Can J Gastroenterol. 1998 Apr 17
• Kidney and liver transplants from donors after cardiac death: initial experience at the London Health Sciences Centre.
  Hernandez-Alejandro, R., Caumartin, Y., Chent, C., Levstik, M. A., Quan, D., Muirhead, N., House, A. A., McAlister, V., Jevnikar, A. M., Luke, P. P., Wall, W.> ;Can J Surg. 2010 Apr
• Join now to see all